Idiotypic manipulation of naive mice has previously been used for induction of systemic autoimmune diseases (e.g., antiphospholipid syndrome, systemic lupus erythematosus, and Wegener's granulomatosis). The aim of this study focused on the utilization of this technique to induce the production of anti-endothelial cells Abs (AECA) and autoimmune vasculitis in a murine model. AECA were derived from a Wegener's granulomatosis patient's plasma. IgG was purified by absorption on a proteinase-3 affinity column resulting in the depletion of anti-neutrophil cytoplasmic Ab activity. The absorbed IgG fraction displayed a high titer of AECA as evidenced by a cyto-ELISA against unfixed human umbilical vein endothelial cells. BALB/c mice were actively immunized with the purified AECA. Three months after a boost injection with the human AECA, mice developed endogenous AECA (AB), but not Abs to proteinase-3, cardiolipin, or DNA. Histologic examination of lungs and kidneys revealed both lymphoid cell infiltration surrounding arterioles and venules; as well as deposition of Igs at the outer part of blood vessel walls. This experimental animal model of vasculitis, a product of our method of idiotypic manipulation, provides the first direct proof for the pathogenicity of AECA.

Download full-text PDF

Source

Publication Analysis

Top Keywords

idiotypic manipulation
8
wegener's granulomatosis
8
aeca
7
pathogenic role
4
role anti-endothelial
4
anti-endothelial cell
4
cell antibodies
4
antibodies vasculitis
4
vasculitis idiotypic
4
idiotypic experimental
4

Similar Publications

Neonatal immunization prevents the development of a chronic autoimmune response against CD4 caused by HIV-1 gp120 in rats.

Immunol Res

June 2023

Laboratory of Molecular and Cell Immunology, Department of Immunology and Cell Biology, Udmurt State University, 1, Universitetskaya St., Izhevsk, 426034, Russian Federation.

Article Synopsis
  • The AIDS autoimmune hypothesis suggests that managing autoimmunity against CD4 T lymphocytes could improve HIV infection outcomes.
  • The study explores using neonatal immunization with gp120 to prevent the harmful autoimmune response against CD4 lymphocytes initiated by HIV-1.
  • Results from both computer modeling and experimental studies indicate that neonatal immunization can suppress the production of anti-CD4 autoantibodies, promoting tolerance to CD4 and preventing autoimmune issues in adult rats triggered by gp120.
View Article and Find Full Text PDF

What Can We Learn from Research with Monoclonal Antibody 1F7?

Monoclon Antib Immunodiagn Immunother

December 2022

Department of Microbiology and Immunology, University of Kentucky, Lexington, Kentucky, USA.

1F7 is a monoclonal antibody that recognizes an idiotypic determinant expressed on primate antibodies binding to HIV-1 and hepatitis C proteins. This monoclonal antibody was used as a tool to dissect the immune response in humans infected with HIV-1 and hepatitis B. Furthermore, 1F7 was also used to manipulate the immune response against HIV-1 in macaques.

View Article and Find Full Text PDF

Rapid single B cell antibody discovery using nanopens and structured light.

MAbs

January 2020

b Department of Therapeutic Discovery, Amgen Research , Burnaby , Canada.

Article Synopsis
  • The study presents a rapid and flexible technique called NanOBlast for screening antibodies from single B lymphocyte cells, crucial for developing therapeutic antibodies.
  • This method involves isolating antibody-secreting cells from mice, screening their secreted antibodies using advanced microfluidic technology, and identifying high-affinity anti-idiotypic mAbs.
  • The entire antibody discovery process can be completed in under 60 days, significantly speeding up drug development and enabling precise assays for measuring therapeutic IgG levels in patient serum.
View Article and Find Full Text PDF

Strategies for Generating Diverse Antibody Repertoires Using Transgenic Animals Expressing Human Antibodies.

Front Immunol

April 2019

Biologics Discovery, Department of Therapeutic Discovery, Amgen British Columbia Inc., Burnaby, BC, Canada.

Therapeutic molecules derived from antibodies have become a dominant class of drugs used to treat human disease. Increasingly, therapeutic antibodies are discovered using transgenic animal systems that have been engineered to express human antibodies. While the engineering details differ, these platforms share the ability to raise an immune response that is comprised of antibodies with fully human idiotypes.

View Article and Find Full Text PDF

The current state of food allergy therapeutics.

Hum Vaccin Immunother

October 2017

b Kaiser Permanente , San Diego , CA , USA.

The prevalence of IgE mediated food allergy is an increasing public health concern. The current standard of treatment is strict avoidance of the offending food(s). There are no FDA approved treatments for food allergy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!